» Articles » PMID: 15956529

Diffusion-weighted and Fluid-attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease: High Sensitivity and Specificity for Diagnosis

Overview
Specialty Neurology
Date 2005 Jun 16
PMID 15956529
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Abnormalities on diffusion-weighted images (DWIs) and fluid-attenuated inversion recovery (FLAIR) images are reported in Creutzfeldt-Jakob disease (CJD). To our knowledge, no large study has been conducted to determine the sensitivity and specificity of DWI and FLAIR imaging for diagnosing CJD.

Methods: Two neuroradiologists, blinded to diagnosis, retrospectively evaluated DWI and FLAIR images from 40 patients with probable or definite CJD and 53 control subjects with other forms of dementia and rated the likelihood of CJD on the basis of the imaging findings.

Results: DWI and FLAIR imaging was 91% sensitive, 95% specific, and 94% accurate for CJD. Interrater reliability was high (kappa = 0.93). Sensitivity was higher for DWI than FLAIR imaging. Abnormalities involved cortex and deep gray matter (striatum and/or thalamus) in 68% of patients with CJD, cortex alone in 24%, and deep gray matter alone in 5%. The most typical and specific patterns were corresponding hyperintensity on both FLAIR images and DWIs confined to the gray matter in the cortex, striatum, medial and/or posterior thalamus, or a combination of these areas. Narrow-window soft-copy review of artifact-free DWIs and FLAIR images and recognition of the normal variation in cortical signal intensity proved critical for successful differentiation of CJD from other dementias.

Conclusion: Because specific patterns of abnormality on DWI and FLAIR images are highly sensitive and specific for CJD, these sequences should be performed whenever CJD is suspected.

Citing Articles

Rapidly progressive dementia: probable sporadic Creutzfeldt-Jakob disease in a Yoruba Nigerian woman with rapidly progressive dementia: a case report.

Idowu A, Ogunmodede A, Sanusi A, Eke U, Oyedele S, Fawale M J Med Case Rep. 2025; 19(1):77.

PMID: 40016859 PMC: 11866802. DOI: 10.1186/s13256-025-05080-x.


Creutzfeldt-Jakob Disease variant presenting with prominent basal ganglia imaging.

Pedrosa D, Carra R, Athayde N, Massruha K, Carvalho R, Gleizer R Einstein (Sao Paulo). 2025; 23:eAI0807.

PMID: 39969023 PMC: 11869790. DOI: 10.31744/einstein_journal/2025AI0807.


Creutzfeldt-Jakob disease: A case report.

Butt F, Dhivagaran T, Naqvi S Radiol Case Rep. 2024; 20(2):1095-1098.

PMID: 39687838 PMC: 11647126. DOI: 10.1016/j.radcr.2024.11.011.


Determination of prion proteins in the diagnosis of Creutzfeldt-Jakob disease using RT-QuIC: A case report from northeastern Colombia.

Lizarazo J, Vargas A, Olarte R, Lizarazo D Biomedica. 2024; 44(4):434-440.

PMID: 39531549 PMC: 11667987. DOI: 10.7705/biomedica.7352.


Sporadic Creutzfeldt-Jakob disease: Brain MRI lesion features from 2 cases reports.

Au H, Lan N, Binh N, Linh L, Hien M, Duc N Radiol Case Rep. 2024; 19(3):939-943.

PMID: 38188942 PMC: 10767313. DOI: 10.1016/j.radcr.2023.11.082.


References
1.
Petzold G, Westner I, Bohner G, Einhaupl K, Kretzschmar H, Valdueza J . False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease. Neurology. 2004; 62(7):1235-6. DOI: 10.1212/01.wnl.0000123265.91365.af. View

2.
Vernino S, Tuite P, Adler C, Meschia J, Boeve B, Boasberg P . Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol. 2002; 51(5):625-30. DOI: 10.1002/ana.10178. View

3.
Kretzschmar H, Ironside J, DeArmond S, Tateishi J . Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996; 53(9):913-20. DOI: 10.1001/archneur.1996.00550090125018. View

4.
Kropp S, Finkenstaedt M, Zerr I, Schroter A, Poser S . [Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease]. Nervenarzt. 2000; 71(2):91-5. DOI: 10.1007/s001150070001. View

5.
Geschwind M, Martindale J, Miller D, DeArmond S, Uyehara-Lock J, Gaskin D . Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003; 60(6):813-6. DOI: 10.1001/archneur.60.6.813. View